Posts Tagged ‘CMS Final Rule’

Despite over 4,000 comments from pharmacists and organizations like Currus, NCPA, the National Association of Chain Drug Stores (NACDS), and others across the country encouraging change, CMS elected not to address DIR reform in their final 2020 drug pricing rule released on Thursday. CMS said in a statement that they “will continue to carefully review…